ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,268, issued on Sept. 29, was assigned to KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (Daejeon, South Korea).

"High-potency SARS coronavirus 2 antigen and vaccine composition comprising same" was invented by Seong Jun Kim (Daejeon, South Korea), Chonsaeng Kim (Daejeon, South Korea), Kyun Do Kim (Daejeon, South Korea), Dae Gyun Ahn (Daejeon, South Korea), Young Chan Kwon (Daejeon, South Korea), Keunbon Ku (Daejeon, South Korea), Hae Soo Kim (Daejeon, South Korea), Hye Jin Shin (Daejeon, South Korea), Gun Young Yoon (Daejeon, South Korea), In Su Hwang (Daejeon, South Korea), Gi Uk Jeong (Daejeon, South Korea), Sun Hee Lee (Daejeon, South Korea), Mi Hwa Kim (Daejeon, South Korea)...